. NCKAP1 is shown in lilac, CYFIP1 in light green with DUF1394 in red, and putative Rac1 interaction residues in blue and highlighted by arrows. Scar/WAVE is in peach, HSPC300 in yellow and ABI1 in orange. d, Phyre2 prediction of the structure of the DUF1394 domain of CYRI-B. The putative Rac1-binding domain of CYRI is shown in blue with Arg160 and Arg161 indicated as a stick representation. e, Sequence alignment of the putative Rac1-binding domain of CYRI in different organisms. The CYFIP Lys189 and Arg190 equivalent residues are well conserved in CYRI (Arg160 and Arg161) and are highlighted in red. f, Sequence alignment covering the N-terminal region of CYRI from representative evolutionarily diverse eukaryotes. UniProt accession numbers are reported. Darker shading represents a greater number of entries with an identical amino acid at this position. The glycine in the second position (highlighted red) is a putative myristoylation site. g,h, Click chemistry analysis of the glycine 2 of CYRI-B. Myristoylation was labelled in HEK293T cells and measured by incorporation of myristate-azide (green) in GFP, CYRI-B WT -GFP or CYRI-B
C ell migration is an ancient and fundamental mechanism whereby cells exert control over interactions with their environment. The actin cytoskeleton is the main driver of cell migration, with dozens of proteins controlling actin organization 1 . Actin protrusions, or pseudopods, govern migration; however, the feedback loops controlling assembly, splitting and disassembly of these structures are an area of active debate 2 . The Scar/WAVE complex is the main driver of Arp2/3-mediated branched actin networks underlying pseudopod generation. The complex consists of five subunits: CYFIP, NCKAP1, Scar/WAVE, ABI and HSPC300 (nomenclature in Supplementary Table 1 ). The main Arp2/3 activating subunit, Scar/WAVE, is autoinhibited until signals trigger a conformational change, exposing an Arp2/3 activation sequence 3, 4 . The Scar/WAVE complex is recruited to acidic phospholipids in the plasma membrane via a patch of basic charges 3 and via interaction with the small GTPase Rac1 [5] [6] [7] . Many motile cell types steer by splitting pseudopods into two or more daughters; selecting pseudopods from the split for retraction or maintenance provides a directional bias steering cells up chemotactic gradients 8 . Actin and associated signal transduction networks form excitable systems that propagate in waves and self-limit to drive protrusion and retraction 1, 9, 10 . Actin and associated cytoskeletal components probably control their own excitability in concert with signalling lipids, but dynamic interplay between 'on' and 'off ' signals is essential for migration to be plastic and responsive.
Negative regulators of the Arp2/3 complex include Gadkin, which sequesters Arp2/3 at the trans Golgi network and endosomes 11 .
Another inhibitor, Arpin, mimics the activating sequence of Scar/ WAVE but inhibits the Arp2/3 complex 12 . Here, we describe a negative regulator of the Scar/WAVE complex, CYRI (encoded by the FAM49 gene)-an evolutionarily conserved protein that mimics the Rac1 interaction domain of CYFIP and promotes dynamic pseudopod splitting.
Results
CYRI is an evolutionarily conserved N-myristoylated protein with homology to CYFIP. We sought new Scar/WAVE complex interactors by precipitating green fluorescent protein (GFP)-fused NAP1 (for nomenclature, see Supplementary Table 1 ) from napA knockout rescued Dictyostelium cells. Reversible formaldehyde cross-linking in cellulo 13 stabilized transient interactions and GFPTrap immunocapture recovered Scar/WAVE, ABI, HSPC300 and PIR121. Another interactor was identified as FAM49 (family of unknown function 49; Fig. 1a and Supplementary Table 2 ). Although FAM49 did not co-precipitate with the Scar/WAVE complex in the absence of cross-linking, we focused on it for two reasons. Firstly, FAM49 is highly conserved across evolution and is roughly co-conserved with the Scar/WAVE complex 14, 15 ( Supplementary Fig. 1a ). Secondly, Pfam and InterPro identified FAM49 as uniquely sharing a domain of unknown function (DUF1394) domain with the Scar/ WAVE complex subunit CYFIP ( Fig. 1b and Supplementary Fig. 1b ). FAM49 proteins comprise mostly DUF1394, while CYFIP proteins contain a cytoplasmic fragile X interaction domain 16 ( Fig. 1b) . We renamed FAM49 CYRI (CYFIP-related Rac1 interactor) in . NCKAP1 is shown in lilac, CYFIP1 in light green with DUF1394 in red, and putative Rac1 interaction residues in blue and highlighted by arrows. Scar/WAVE is in peach, HSPC300 in yellow and ABI1 in orange. d, Phyre2 prediction of the structure of the DUF1394 domain of CYRI-B. The putative Rac1-binding domain of CYRI is shown in blue with Arg160 and Arg161 indicated as a stick representation. e, Sequence alignment of the putative Rac1-binding domain of CYRI in different organisms. The CYFIP Lys189 and Arg190 equivalent residues are well conserved in CYRI (Arg160 and Arg161) and are highlighted in red. f, Sequence alignment covering the N-terminal region of CYRI from representative evolutionarily diverse eukaryotes. UniProt accession numbers are reported. Darker shading represents a greater number of entries with an identical amino acid at this position. The glycine in the second position (highlighted red) is a putative myristoylation site. g,h, Click chemistry analysis of the glycine 2 of CYRI-B. Myristoylation was labelled in HEK293T cells and measured by incorporation of myristate-azide (green) in GFP, CYRI-B WT -GFP or CYRI-B
G2A
-GFP mutant transfected cells (magenta), following GFP immunoprecipitation. Molecular markers are shown in g. Source data are provided in Supplementary  Table 6 ; unprocessed western blots are shown in Supplementary Fig. 7 . Relative incorporation was quantified by densitometry and is reported in h. One-way analysis of variance with Tukey's post-test was applied. ***P < 0.001. n = 3 independent assays. The bars represent means and the error bars s.e.m.
, where active Rac1 stimulates the Scar/WAVE complex to catalyse lamellipodial expansion.
CYRI interacts directly with activated Rac1 in vitro.
Homology between CYRI and CYFIP ( Supplementary Fig. 1b ) suggested potential interaction with Rac1. Yeast two-hybrid screening with Rac1 G12V as bait retrieved CYRI-B from multiple complementary DNA libraries ( Supplementary Fig. 2a ). The core interacting sequence of CYRI-B encompasses amino acids 30-236 (hereafter, the Racbinding domain (RBD)) ( Supplementary Fig. 2b,c) . GFP-RBD expressed in CHL-1 human melanoma cells interacted selectively with glutathione-S-transferase (GST)-Rac1 Q61L but not GST-Rac1
WT . Mutation of CYRI-B R160 or R161 (in GFP-RBD) to aspartic acid abrogated this interaction (Fig. 2a-c and Supplementary Fig. 7 ). The GST-CYRI-B RBD and maltose-binding protein (MBP)-Rac1 also showed robust interaction (Figs 2d-f and Supplementary  Fig. 7 ). In this assay, CYRI does not co-precipitate with Rac1 T17N , Rac1 G12V or Rac1 WT , probably due to the low affinity of CYRI-B for Rac1. However, the double mutant Rac1
P29S/Q61L
, recently shown to have a high affinity for the Scar/WAVE complex 21 , displayed enhanced binding to the CYRI-B RBD (~3-3.5-fold increase) over Rac1 Q61L but no enhanced binding to PAK1-CRIB (Cdc42 and Rac interaction binding) ( Supplementary Figs. 2d-f and 7) . Using surface plasmon resonance (SPR), the immobilized CYRI-B RBD specifically interacted with Rac1 Q61L with an equilibrium dissociation constant (K d ) of 27 µ M, and the reverse assay (with Rac1 Q61L immobilized) returned a K d of 22 µ M (Fig. 2g) . As the CYRI RBD shows no homology to CRIB motifs, we probed the specificity of the interaction of CYRI between Rac1, RhoA and Cdc42. Once again, the CYRI RBD interacted robustly with Rac1 Q61L but not with constitutively active RhoA Q63L or Cdc42 Q61L ( Fig. 2d and Supplementary  Figs. 2g,h and 7) . Thus, the CYRI-B RBD interacts specifically with active Rac1. Two conserved basic residues in the DUF1394 region (conserved in CYFIP) mediate this interaction. This suggests a signal-regulated interaction between active Rac1 and CYRI, similar to the Rac1-CYFIP interaction, defining DUF1394 as an active Rac1 interaction module.
CYRI interacts with active Rac1 in cells. Next, we explored the Rac1-CYRI interaction in cells. Proximity ligation 22 revealed an interaction between Rac1
WT and CYRI-B in COS-7 cells, as well as a stronger interaction between Rac1 Q61L and CYRI-B (Fig. 2h,i and Supplementary Fig. 2i-l . CYRI-GFP did not co-localize with a control mitochondrial reporter mCherry-gemA tail (PCC = − 0.06, s.d.: 0.15, n = 6 cells). Thus, CYRI interacts with activated Rac1, mediated by key conserved arginines, in both mammalian and Dictyostelium cells.
CYRI opposes recruitment of the Scar/WAVE complex to lamellipodia. Knockdown or knockout of cyri-b by small interfering RNA (siRNA) or clustered regularly interspaced short palindromic repeats (CRISPR) in COS-7 or CHL-1 cells did not affect proliferation, but promoted unusually large and broad lamellipodia highly enriched in WAVE2 (Fig. 3a,b and Supplementary Figs. 3a-g and 7) . Cells spread over a larger area and adopted a 'fried egg' phenotype, correlating with an increase in circularity (Fig. 3c,d and Supplementary Fig. 3e-g ). Expression levels of Scar/WAVE complex subunits are not obviously altered in cyri-b knockout cells ( Supplementary Figs. 3h and 7) . Cell area and circularity were both rescued by re-expression of untagged CYRI-B WT , but not the Rac1-non-binding R160/161D mutant (Fig. 3e,f and Supplementary Figs. 3i-k and 7). CYRI-B G2A , which cannot be N-myristoylated, failed to rescue the phenotype (Fig. 3g,h and Supplementary Figs. 3l,m and 7), reinforcing the importance of CYRI lipid modification. cyri knockout Dictyostelium cells also showed enhanced recruitment of the Scar/WAVE complex (GFP-HSPC300 reporter) to a much broader leading edge ( Supplementary Fig. 3n , yellow dotted line, and Supplementary Video 1). Moreover, Scar/WAVE patches in cyri knockout cells were ill-defined but longer lived, suggesting CYRI's ability to suppress Scar/WAVE complex activity outside active protrusions ( Supplementary Fig. 3n , heat map). We conclude that CYRI, via its interaction with active Rac1 and membrane targeting, opposes the active Scar/WAVE complex at the plasma membrane and thus drives the formation of more focused and sharper lamellipodial protrusions.
To determine the requirement for Rac1 for the phenotype of cyri-b knockout cells, we co-depleted Rac1 and CYRI-B from mouse tail skin fibroblasts with the ROSA26-Cre::ER
Rac1
fl/fl (flox/flox) genotype 24 , treated with hydroxytamoxifen (OHT, to induce deletion of Rac1) and then with siRNA against cyri-b ( Supplementary Figs. 3o and 7) . Deletion of Rac1 led to a spindle-shaped morphology and a loss of lamellipodia, as previously described [25] [26] [27] . Loss of CYRI-B did not cause excessive lamellipodia or rescue circularity in Rac-deleted cells (Fig. 3i-k) . Thus, Rac1 is definitely required for CYRI-B-driven actin reorganization.
The increased circularity of cyri-b-depleted cells is reminiscent of Rac1 hyperactivation phenotypes 28 , suggesting that CYRI-B might buffer Rac1 activity. Indeed, a dark acceptor mTq2-sREACH Raichu Förster resonance energy transfer (FRET) probe 29, 30 showed a consistent increase in Rac1 signalling activity in CYRI-B-depleted cells, as measured by FRET efficiency in both COS-7 (Fig. 3l,m) and CHL-1 cells ( Supplementary Fig. 3p,q) , which was confirmed by biochemical pull-down (Fig. 3n,o and Supplementary Fig. 7 ). Together, these data indicate an increase in Rac1 signalling activity GST-Rac1  GST-Rac1  GST-Rac1   GFP  GFP-RBD R161D  GFP-RBD WT  GFP-RBD R160D  eCFP-CRIB-PBD   55  40   35   25  55   40   35 25 Table 6 . Unprocessed western blots are shown in Supplementary Fig. 7 . . In l, n = 45 for WT, n = 57 for cyri KO, n = 53 for cyri KO + CYRI WT and n = 31 for cyri KO + CYRI R155/156 . In m, n = 42 for WT, n = 62 for cyri KO, n = 46 for cyri KO + CYRI WT and n = 33 for cyri KO + CYRI R155/156 . In n, n = 2,389 for WT, n = 2,460 for cyri KO, n = 3,024 for cyri KO + CYRI WT and n = 1,169 for cyri KO + CYRI R155/156 . o, Needle assay using WT or cyri knockout Ax3 cells with cAMP (see also Supplementary Video 8). Yellow asterisks indicate tip of micropipette. Scale bars, 25 μ m. p, Spider plots of the results in o during 0-100 s. n = 86 for WT and n = 79 for cyri KO. a-p represent three biologically independent experiments. Means and s.e.m. are shown unless otherwise indicated. n represents the number of cells in all panels. Statistical significance in b-d and k-n was determined by one-way analysis of variance with Dunn's post-test. NS, not significant (P > 0.05); *P ≤ 0.05; **P ≤ 0.01; ***P ≤ 0.001. Whisker plots show the 10th-90th percentiles in b and k-m, and the 1st-99th percentiles in n, along with the median (bar) and mean (cross). Source data are provided in Supplementary Table 6 . in CYRI-B-depleted cells. Conversely, inducible overexpression of untagged CYRI-B (Supplementary Figs. 4a,b and 7 ) resulted in fractal-like lamellipodia, decreasing WAVE2 recruitment, cell area and circularity (Fig. 4a-d and Supplementary Fig. 4c-f , vehicletreated controls). In parallel, overexpression of CYRI-B also drove a decrease in the Rac1 activity signal of the Raichu FRET probe (Fig. 4e,f) , which was fully reversed by the R160/R161 double mutation (Fig. 4g) . Thus, CYRI-B opposes Rac1-Scar/WAVE-mediated expansion of lamellipodia protrusions. Adding a GFP tag to either end of CYRI-B interfered with its function, precluding dynamic analysis. Likewise, available antibodies to FAM49B did not give specific staining by immunofluorescence, but CYRI-B-FLAG showed significant co-enrichment with WAVE2 at leading pseudopods (Fig.  4h,i) . Thus, CYRI co-accumulates with WAVE2 at lamellipodium protrusions. Overall, cyri-b knockout cells show broader Scar/ WAVE-driven lamellipodia and increased Rac1 activation, supporting a role for CYRI-B as a buffer of Rac1 and Scar/WAVE complex activation activity at the leading edges of cells.
CYRI regulates the duration and extent of protrusions. Next, we sought to determine the consequences of CYRI-B depletion for lamellipodial actin dynamics. First, we observed actin dynamics live using fast-frame-rate videos in CHL-1 cells expressing GFP-LifeAct (Fig. 5a , left panels, and Supplementary Video 2). We tracked the cell edge and used unwrapped (polar) kymographs (Fig.  5a , middle panels) to visualize and measure the area of protrusion (yellow) versus retraction (purple) over time. Control cells showed small but rapid bursts of actin-based protrusion (yellow patches on the kymographs), while cyri-b knockouts had longer-lived, less dynamic responses (Fig. 5a,b) . If CYRI-B buffers Rac1 at the lamellipodium, we speculated that cyri-b knockout cells would struggle to restrain protrusion formation on Rac1 activation. To investigate this, we used the Rac1-LOV (light, oxygen or voltage) optogenetic probe, which triggers activation of Rac1 with blue light 31 . Rac1 was activated with pulses of blue light in a discrete area on the cell periphery (Fig. 5c,d and Supplementary Video 3) . Cyri-b knockout cells showed a more sustained and extensive protrusion response and increased peripheral propagation of lamellipodia (Fig. 5e-g ). Thus, CYRI-B limits Rac1-mediated activation of the Scar/WAVE complex and shortens the Rac1-activated protrusion.
CYRI focuses actin assembly in leading pseudopods to promote plasticity of migration. Plasticity of protrusion is important for directional migration, such as during chemotaxis. CHL-1 melanoma cells are normally nearly static when seeded at low density in two-dimensional culture, but cyri-b knockout cells migrated 1.5-2-fold faster (Fig. 6a,b and Supplementary Video 4) . Cyri-b knockout cells frequently assumed a C shape, with a broad-spread lamellipodium at the front half of the cell and a convex rear resembling the fast-moving goldfish keratocyte 32 ( Supplementary Fig. 5a , yellow arrows, and Supplementary Video 4). C-shaped cells moved faster than the other common shapes (Fig. 6c,d) , and the C shape correlated with faster migration (Fig. 6e,f and Supplementary Fig. 5b,c) . Lamellipodia need to be polarized and dynamic for efficient cell migration 27, 33 , so when cyri-b knockout cells became polarized into a C shape, they gained motility.
Since cells need to maintain plasticity of their lamellipodia to respond effectively to directional cues 34 , we predicted that depletion of CYRI-B would affect chemotactic migration. CHL-1 cells are not chemotactic to serum, but WM852 melanoma cells are highly chemotactic 35 . Loss of CYRI-B (Supplementary Figs. 5d ,e and 7) severely affected chemotaxis of these cells towards a 10% serum gradient with no effect on basal speed; knockouts often migrated very long distances in the opposite direction to the chemoattractant gradient, having lost the plasticity to reorient towards the gradient (Fig.  6g-i and Supplementary Video 5) . Thus, CYRI-B strongly impacts how cells polarize and remodel their lamellipodia and reorient during directed migration.
CYRI promotes pseudopod splitting and opposes persistent migration in Dictyostelium. We examined Dictyostelium Ax3 cells (cyri knockout and rescue; Supplementary Figs. 5f and 7) migrating under agarose up self-generated gradients of the chemoattractant folate 36 ( Supplementary Fig. 5g ). Similar to CHL-1 cells, cyri knockout cells were rounder, with blunted pseudopods (Fig. 6j,k and Supplementary Videos 6 and 7) . Dictyostelium cells primarily turn by splitting their leading pseudopod into differently oriented daughters 8 ; automated segmentation and tracking revealed that cyri knockouts generated fewer protrusions per minute (Fig. 6l) , and showed fewer splits (from ~5 min −1 to ~2 min −1 ; Fig. 6m ) and decreased speed (Fig. 6n) . Cells still oriented towards the folate gradient, but their less efficient turning was clearly reflected by a smaller angle of turn between steps (Supplementary Fig. 5h ). Thus, CYRI promotes pseudopod splitting in Dictyostelium cells, which is dispensable for gradient sensing, but compromises the speed of migration and reorientation while steering.
We rescued Dictyostelium cyri knockouts with CYRI WT or CYRI R155/156D as stable, single-copy transfectants 37 under an actin15 promoter (Fig. 6j -n and Supplementary Videos 6 and 7). CYRI WT -expressing cells exhibited more numerous fractal pseudopods, as well as decreased circularity and an enhanced frequency of protrusion generation and pseudopod splitting (Fig. 6j-m) even over WT cells. Rescue with CYRI WT also restored cells' ability to turn during chemotaxis ( Supplementary Fig. 5h ).
Another widely used chemotaxis assay involves a chemoattractant-filled microneedle introduced next to the Dictyostelium cells, inducing new pseudopods directly towards the needle, and consequently reorienting the cells. When cyclic AMP (cAMP)-sensitive cyri knockout or rescue cells were challenged with cAMP in a needle assay, cyri knockouts were initially unable to form new pseudopods (Fig. 6o) , while CYRI WT cells rapidly protruded pseudopods and reoriented towards the needle (Fig. 6o,p and Supplementary Video 8) . Cyri knockouts eventually elongated and streamed towards the needle, but they maintained resistance to new pseudopod formation and rapid reorientation. Thus, cells that lack CYRI can still sense an attractant gradient, but their broad and unfocused protrusions split rarely, and their diminished ability to generate new pseudopods cripples their response to changing gradients.
Modelling CYRI's role in pseudopod plasticity. Since CYRI affects the plasticity of pseudopod dynamics, we likened its activity to the mathematical model of Meinhardt 38 , where local inhibitors are recruited by an activation signal and limit the amount of cell edge devoted to pseudopods. Actin assembly pathways are not linear cascades, but rather feedback loops where positive stimulation is self-reinforcing and causes further activation until it is overcome by negative feedback 1, 10 . In models of migration based around positive feedback, a locally acting inhibitor is also needed to destabilize existing pseudopods, so the cell can change direction. Without this, cells polarize, but cannot turn to migrate towards an attractant. We used a modified version of a published simulation 39 based on the Meinhardt model 38 to visualize the concentrations of the activator and the local inhibitor at the cell edge ( Supplementary  Fig. 5i and Supplementary Video 9), to illustrate how CYRI-B regulates Rac1 and Scar/WAVE signalling. A peak in the activator (which represents active Rac1 and Scar/WAVE) results in the formation of a new pseudopod. The peak also causes an increase in the concentration of the local inhibitor, which is smaller and thus diffuses faster 38 . Initially, the inhibitor limits the lateral spread of the pseudopod ( Supplementary Fig. 5i, panel 1) ; later, levels of inhibitor rise in the middle of the pseudopod, destabilizing it and causing a split ( Supplementary Fig. 5i, panel 2) . The weaker of the pseudopods then retracts and the stronger is reinforced until the cycle of inhibition catches up with it and re-starts the splitting cycle ( Supplementary Fig. 5i, panels 3-4) . The local inhibitor thus increases both the morphological complexity of the cell and the competition between pseudopods. This is supported by the lack of pseudopod splitting in Dictyostelium and our optogenetic data showing that protrusions in cyri knockout cells are more long-lived and spread laterally to a greater extent. Thus, Meinhardt's model offers insight into the role of CYRI proteins as local inhibitors, which enhance leading-edge dynamics and add plasticity to the positive feedback loops driving migration.
CYRI-B regulates epithelial polarity via a Rac1-dependent mech-
anism. Finally, we tested a role for CYRI-B in the polarized epithelial cyst 40, 41 where asymmetric Rac1 activation is also crucial. As cells form a cyst, they establish a lumen via selective membrane trafficking and polarized recruitment/activation of cytoskeletal components 42 . Specific spatial regulation is dependent on matrix and adhesions, but Rac1 activation also regulates lumen formation 43 and is specified by differential recruitment of the guanine nucleotide exchange factor-T cell lymphoma invasion and metastasis 1 (GEF TIAM1) across the cyst, leading to an apico-basal activation gradient 40 . We hypothesized that CYRI-B might help maintain the Rac1 activation gradient, allowing Scar/WAVE complex recruitment and activation to be spatially controlled during cyst formation. Indeed, knockdown of cyri-b using short hairpin RNA (shRNA) in Madin-Darby canine kidney (MDCK) cells (Supplementary Figs. 6a,b and 7) led to a multilumen phenotype during cyst formation, similar to deregulation of active Rac1 (Fig. 7a,b) 
42
. WAVE2 is normally prominently localized to the basolateral surfaces of the cysts, but mostly absent from the luminal surface, as marked by podocalyxin (PODXL) (Fig. 7c) . However, when CYRI-B was depleted, WAVE2 staining was increased at the luminal periphery, coincident with PODXL staining (Fig. 7c) . Mislocalization of the actin cytoskeleton machinery to cyst luminal surfaces results in aberrant orientation of the mitotic cleavage plane during polarized cell division, which occurred in cyri-b knockdown cysts ( Supplementary  Fig. 6c-e) . To test whether the multilumen phenotype was due to inappropriate Rac1 activation, we used moderate concentrations of either EHT1864 (Fig. 7d,e) or NSC23766 (Supplementary Fig. 6f ) to dampen Rac1 activity; these both provided a substantial rescue. Thus, loss of CYRI-B destabilized epithelial polarity during the formation of epithelial cell cysts by allowing inappropriate Rac1-mediated recruitment of the actin machinery to the nascent luminal surface. CYRI-B thus maintains spatial regulation of activation of the Scar/WAVE complex by dynamic buffering of Rac1.
Discussion
CYRI is highly conserved and DUF1394 represents a Rac1 interaction module. CYRI proteins are highly conserved in eukaryotes and function as Rac1 interaction modules that directly limit Rac1-mediated lamellipodia extension. The DUF1394 domain of CYRI comprises the Rac1-binding site and is shared with CYFIP proteins of the Scar/WAVE complex. This interaction requires two highly conserved arginine/lysine residues, previously described on CYFIP1 (ref. ). CYRI, like CYFIP1, is specific for activated Rac1 over RhoA and Cdc42. Myristoylation of glycine 2 of CYRI may allow recycling of CYRI between active pseudopods and the cytoplasm or membrane vesicles 44 . The Rac1-interacting formin FMNL2 is also myristoylated 45 , implying potential common mechanisms for recruitment to actin protrusions. CYRI has no homology to GTPase activating proteins, so it probably does not alter nucleotide hydrolysis by Rac1. Why would a cell need CYRI if it has Rac-GTPase activating proteins? We propose that CYRI could be a specific buffer for Scar/ WAVE-driven lamellipodium plasticity, rather than a general protein to turn off Rac1.
CYRI opposes recruitment of the active Scar/WAVE complex to leading edges and promotes plasticity. Modulating the levels of CYRI differently affected cell speed in the cell types we assayed. While this may seem paradoxical, the basal speeds of these cell types and modes by which they migrate are different. Furthermore, migration speed is multiparametric, being the result of a combination of protrusion, adhesion and directionality/persistence. Migration speed is thought to require optimal levels of Rac1 activation and can be slowed by too little/too much active Rac1 (ref. 33 ). Dictyostelium are optimized by nature to be fast-moving and relatively non-adhesive, so nearly any change will result in slower migration. In contrast, the speed of adhesive slow-moving cancer cells may benefit from removing the brakes on Rac1 activity.
Negative regulators of the Arp2/3 complex have been described 11, 12, 46 , but thus far, CYRI is the only negative regulator of the Scar/WAVE complex. Importantly, it is widely conserved in evolution along with the Scar/WAVE complex, making it a universal negative regulator. CYRI and CYFIP probably resulted from an ancient gene duplication and retained the same Rac1-binding function, placing CYRI as a Meinhardt local inhibitor 38 . However, a local inhibitor should be present at high enough concentration to compete with the activator. A recent quantitative mass spectrometry study estimated concentrations of CYRI-B to be fourfold higher in protein copy number than the Scar/WAVE complex 47 in three of four cell lines (A549: fourfold; HepG2: fivefold; PC3: 4.4-fold; and U87: 0.53-fold, based on comparison with CYFIP1). Thus, there is probably enough CYRI-B in cells to compete with the Scar/WAVE complex for Rac1 binding.
CYRI provides spatiotemporal regulation of the connection between Rac1 and the Scar/WAVE complex.
Cell migration involves cycles of protrusion and retraction coupled with adhesion to produce forward locomotion 48 . Cells with wild-type (WT) levels of CYRI showed rapid protrusion-retraction dynamics indicative of transient activation of the Scar/WAVE complex (for example, the kymograph in Fig. 5a ). cyri knockouts showed broader and more sustained lamellipodia and increased Scar/WAVE recruitment, placing CYRI as a key part of the feedback loop controlling leading-edge actin dynamics, in line with Arpin, a negative regulator of the Arp2/3 complex 12 , and Coronin, which positively regulates Rac1 activation 1, 49, 50 . Breaking the feedback loop by deleting CYRI affected both Scar/WAVE recruitment and Rac1 signalling activity. Thus, the actin machinery feeds back to Rac1 dynamically. This dynamic feedback is necessary for cells to change direction and respond with plasticity to stimuli such as chemotactic gradients.
CYRI also regulates the polarized function of the Rac1-Scar/ WAVE complex in epithelial cells in three dimensions. Epithelial cells establish a Rac1 gradient that maintains polarity by asymmetric distribution of β 2-syntrophin and Par3 (ref. 40 ). Par3, localized apically, inhibits the Rac-GEF TIAM1, while β 2-syntrophin, localized basally, activates TIAM1. This gradient is required for proper luminogenesis. CYRI helps direct the formation of a single polarized lumen by regulating the Rac1 gradient required for proper spindle orientation. A role for CYRI in epithelia could have broad implications for development and cancer.
Cell migration is the outcome of feedback loops that control the dynamics of cell shapes 10, 38, [51] [52] [53] . Travelling and spreading wave patterns (for example, refs 10, 51 ) manifest in actin-based protrusions, implying positive feedback loops. However, negative feedback is also required 38 to prevent uniform activation. Actin and actin-binding proteins can comprise an excitable system 10,52 also modulated by systems involving small GTPases, kinases and signalling lipids (for example, ref. ). Our data imply that CYRI acts at the interface; by competing with Scar/WAVE (an actin-nucleating complex) for Rac1 (a small GTPase), it connects signalling with actin polymerization, moderating excitable behaviours.
In conclusion, we propose that CYRI is a highly conserved regulator of the dynamics of the Rac1-Scar/WAVE pathway, providing plasticity and adding complexity to leading-edge dynamics.
Online content
Any methods, additional references, Nature Research reporting summaries, source data, statements of data availability and associated accession codes are available at https://doi.org/10.1038/ s41556-018-0198-9. Supplementary Tables 3 and 4 , respectively. Alignment and phylogenetic tree. Protein sequences were obtained from UniProt (http://www.uniprot.org/) and aligned using MacVector software. The phylogenetic tree was constructed based on the major eukaryotic superclasses, as previously defined 14 , and based on previous identification of Arp2/3 complex and Scar/ WAVE complex sequences 15, 54 . A BLAST homology search was performed on the National Center for Biotechnology Information website (https://blast.ncbi.nlm.nih. gov/Blast.cgi). Dictyostelium, human or a close relative were searched against the complete translated genome of open reading frames from these organisms.
Methods

Antibodies and constructs. Antibodies and DNA constructs are listed in
A hidden Markov model logo was generated by feeding the Pfam database of the DUF1394 domain into Skylign 55 .
CYRI-B structure prediction. The predicted protein structure of CYRI-B was generated by Phyre2 56 using the cytoplasmic fmr1-interacting protein 1 (PDB 3P8C) as a template with 100% homology confidence and 18% sequence identity.
Mammalian cell lines and growth conditions. CHL-1, HEK293T and COS-7 cells were maintained in Dulbecco's modified Eagle's medium supplemented with 10% foetal bovine serum (FBS) and 2 mM l-glutamine (DMEM). ; Cyri-B fl/fl mouse embryonic fibroblasts were maintained in DMEM complemented with 1 mg ml −1 of primocin. COS-7 cells transfected with the doxycycline-inducible system were grown in 10% tetracyclin-free FBS (Clontech) and treated with 5 μ g ml −1 doxycycline for 48 h.
ROSA26:CreER
MDCK cells were maintained in 5% FBS and 2 mM l-glutamine-supplemented minimum essential high-glucose and high-sodium bicarbonate medium.
WM852 cells were grown in Roswell Park Memorial Institute medium (RPMI) supplemented with 10% FBS and 2 mM l-glutamine.
All mammalian cell lines used in this study were maintained in 10 cm plastic dishes at 37 °C and under 5% CO 2 .
Cell lines were regularly tested for Mycoplasma contamination (MycoAlert; Lonza).
Click chemistry of mammalian CYRI-B.
HEK293T cells plated on a 24-well plate were transfected with 1 μ g of pEGFPN1 or CYRI-B-EGFP (WT or G2A mutant) using Lipofectamine 2000 and processed the next day. C14:0-azide was synthesized as previously described 57 . Transfected HEK293T cells were incubated with 100 μ M of C14:0-azide (in DMEM with 1 mg ml −1 defatted bovine serum albumin (BSA)) for 4 h at 37 °C. Cells were washed twice in phosphate buffered saline (PBS) and lysed on ice for 10 min in 100 μ l lysis buffer (150 mM NaCl, 1% Triton X-100, 50 mM Tris-HCl, pH 8.0, containing protease inhibitors). Cell lysates were centrifuged at 10,000g for 10 min at 4 °C to remove cell debris. 800CW Alkyne Infrared Dye was conjugated to C14:0-azide for 1 h at room temperature with end-over-end rotation by adding an equal volume of freshly mixed click chemistry reaction mixture (10 μ M 800CW Alkyne Infrared Dye, 4 mM CuSO 4 , 400 μ M Tris[(1-benzyl-1H-1,2,3-triazol-4-yl)methyl]amine and 8 mM ascorbic acid in distilled water) to the supernatants. GFP-tagged proteins were isolated using the μ MACS GFP isolation kit following the manufacturer's protocol and resolved by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) as described below. Protein acylation was quantified by expressing the intensity of the click signal relative to the protein signal.
Yeast two-hybrid screen. Screening was performed at Hybrigenics Services per their standard protocols. Briefly, the coding sequence for the constitutively active full-length Rac1 (NM_006908.4; mutations G12V and C189S) was PCR-amplified and cloned into pB27 as a carboxy (C)-terminal fusion to LexA (LexA-Rac1). All libraries use the prey vector pP6. pB27 and pP6 are derived from the original pBTM116 (ref. 58 ) and pGADGH 59 plasmids, respectively. The bait was screened against the different libraries using a mating approach with YHGX13 (Y187 ade2-101::loxP-kanMX-loxP; mat alpha) and L40deltaGal4 (mat-a) yeast strains as previously described 60 . Positive colonies were selected on a medium lacking tryptophan, leucine and histidine, and supplemented with 3-aminotriazole. The prey fragments of the positive clones were amplified by PCR and sequenced at their 5′ and 3′ junctions. Interacting proteins were identified in the GenBank database (National Center for Biotechnology Information).
GST pull-down of mammalian CYRI-B and GTPases. DH5alpha Escherichia coli cells were grown until absorbance at 600 nm of 0.4 and induced for 4 h with 0.2 mM isopropyl β -d-1-thiogalactopyranoside (IPTG). The pellet was resuspended in ice-cold buffer A (50 mM NaCl, 50 mM Tris-HCl pH 7.5, 5 mM MgCl 2 , 3 mM dithiothreitol (DTT)) and sonicated, followed by a 30 min spin at 20,000 r.p.m. to yield lysate. GST-tagged proteins were immobilized on pre-washed glutathione sepharose beads for 30 min at 4 °C with gentle agitation, and unbound proteins were washed out three times in buffer A.
Cells transfected with GFP constructs were collected in ice-cold lysis buffer (100 mM NaCl, 25 mM Tris-HCl pH 7.5, 5 mM MgCl 2 , 1× protease and phosphatase inhibitors, 0.5% NP-40). Then, 1.5-2 mg of proteins were mixed with pre-equilibrated beads with gentle agitation for 2 h at 4 °C. Beads were then washed three times in washing buffer (100 mM NaCl, 25 mM Tris-HCl pH 7.5, 5 mM MgCl 2 ), resuspended in sample buffer containing DTT and resolved by SDS-PAGE as described below.
MBP pull-down. Recombinant proteins were purified as mentioned above and immobilized on MBP-Trap beads. Beads were mixed with a similar amount of recombinant GST-tagged proteins in ice-cold buffer A (see above) containing 0.05% Triton X-100. Binding was allowed for 2 h at 4 °C and the beads were then thoroughly washed in ice-cold buffer A. Proteins were eluted by adding boiling sample buffer directly to the beads and prepared for SDS-PAGE.
Mutagenesis of mammalian CYRI-B.
A point mutation was inserted using the Q5 Site-Directed Mutagenesis Kit (New England Biolabs) and following the manufacturer's instructions. Primers were designed using NEBaseChanger (see Supplementary Table 5 ).
Protein purification for SPR analysis. E. Coli BL21-CodonPlus (DE3)-RIL (Agilent Technologies) and E. Coli BL21(DE3)pLysS (Promega) were used for GSTtagged and His-tagged proteins, respectively.
Pre-culture was grown overnight in lysogeny broth containing the appropriate antibiotics. Once until absorbance at 600 nm of 0.4 was reached, protein expression was induced using 0.2 mM IPTG, and the culture was kept overnight at 20 °C under agitation (200 r.p.m.). Cells were lysed in Buffer 1 (200 mM NaCl, 30 mM Tris-HCl pH 7.5, 5 mM MgCl 2 , 3 mM β -mercaptoethanol) containing protease inhibitors and passed through a 20,000 psi pressurized microfluidizer. The soluble fraction was collected by centrifugation (30 min at 20,000 r.p.m.) and loaded onto an equilibrated GSTrap HP or HisTrap HP column using an AKTA machine (GE Healthcare). Proteins were directly eluted using Buffer 1 containing either 20 mM GSH for GST-tagged proteins or 300 mM imidazole pH 7.5 for His-tagged proteins. Cleavage on the column was performed overnight with the appropriate protease, flowing at 0.1 ml min −1 in a loop connected to the AKTA machine. Proteins were gel purified (HiLoad 16/600 Superdrex 75 pg or HiLoad 16/600 Superdrex 200 pg) in Buffer 2 (150 mM NaCl, 25 mM Tris-HCl pH 7.5, 5 mM MgCl 2 , 2 mM β -mercaptoethanol), snap-frozen and stored at − 80 °C. SPR protein-binding assay. SPR analysis was performed using a Biacore T200 system (GE Healthcare) equilibrated with Buffer 2 (see above) supplemented with 0.5% of surfactant P20. GST-tagged proteins were immobilized at 22 °C onto a CM5 sensor chip functionalized with anti-GST and reached ~320 response units. The same procedure was used for His-tagged protein onto an NTA sensor chip and reached 650 response units. All immobilization steps were done at a flow rate of 10 μ l min . Data were solvent corrected, reference subtracted, quality controlled and evaluated using the Biacore T200 evaluation software. Affinity was determined by curve fitting a 1:1 binding model.
To produce siRNA oligonucleotides targeting CYRI-B (Qiagen), mouse tail fibroblasts and COS-7 cells were respectively treated with 75 nM of Mus musculus CYRI-B siRNA and 25 nM of Homo sapiens CYRI-B siRNA also recognising COS-7 simian sequences, or a matched concentration of control siRNA (AllStars Negative siRNA; Qiagen) was transfected using Lullaby transfection reagent according to the manufacturer's instructions. The same step was repeated 48 h later and the cells were analysed after 24 h.
For CRISPR-Cas9-mediated knockout, single-guide RNA was selected using the MIT CRISPR design tool (http://crispr.mit.edu/). Annealed oligonucleotides were cloned into pLentiCrispRv2-Puro. Briefly, HEK293T cells were seeded at 1.5 × 10 6 cells per 10 cm dish. Cells were transfected with 10 μ g of the selected plasmid (vector Ctr or containing a guide RNA against CYRI-B), 7.5 μ g of pSPAX2 (Addgene 8454) and 4 μ g of pVSVG (Addgene 12260) in a final volume of 440 μ l of sterile water, and complemented with 500 μ l 2× HEPES-buffered saline (HBS) and 120 mM CaCl 2 . Solution was incubated 30 min at 37 °C before adding to HEK293T cells. Medium was removed after 24 h and replaced by 6 ml of 20% FBS DMEM. Meanwhile, recipient cells were plated at 1 × 10 6 cells per 10 cm dish. The day after, supernatants were filtered through a 0.45 μ m pore membrane and mixed with 25 μ g of hexadimethrine bromide (for a final concentration of 4.2 μ g ml −1 ) before infecting recipient cells. Infection was repeated the next day, and stably transfected cells were selected with 1 μ g ml
of puromycin.
The same procedure was used for lentiviral infection of the MDCK cells, and cells were selected with 5 μ g ml −1 of puromycin. For CRISPR COS-7 cyri-b knockout cells, human guide RNAs against cyri-b (CRISPR #2 or #4; see Supplementary Table 5) were cloned into a pSpCas9(BB)-2A-GFP vector (Addgene plasmid 48138) using the restriction enzyme BbsI as described previously 61, 62 . COS-7 cells were seeded onto 6 cm dishes and transfected the day after using Lipofectamine 2000 with 5 μ g of pSpCas9(BB)-2A-GFP (empty vector or cyri-b-targeting CRISPR guide RNA) following the manufacturer's guidelines. Cells were grown for approximately 24 h before fluorescence activated cell sorting (FACS). The transfected cells were trypsinized, resuspended in serumfree DMEM with 4′ ,6-diamidino-2-phenylindole (1 μ g ml ) and filtered through a 0.45 μ m pore membrane for FACS. For FACS, gates were drawn to sort by cell size, live/dead and GFP-positive cells. GF-positive sorted cells were incubated with complete DMEM and left to grow under normal culturing conditions. Knockouts for cyri-b were analysed by western blotting.
Knockout mouse embryonic fibroblast and mouse tail skin fibroblast cell lines were generated by adding 1 μ M of OHT in the growth medium every 3 d over 7 d.
FRET imaging of mammalian cells. The Rac1-Raichu-mTq2-sREACH probe is described in ref. 29 . Cells were transfected with the probe, plated the day after on laminin and imaged. FRET images were acquired with the Nikon fluorescence lifetime imaging (FLIM)/TIRF system Z6014 microscope equipped with a Plan Apochromat 63× /1.45 oil objective and a 465 nm light-emitting diode (LED). Dishes were placed in a 37 °C heated chamber perfused with 5% CO 2 . The FRET efficiency was calculated by standardizing the probe lifetime to the average lifetime of the donor alone as follows:
Average lifetime of donor Lifetime of probe Average lifetime of donor 100
Active Rac1 pull-down. COS-7 cells were plated on laminin-coated dishes for 1 h, washed twice with ice-cold PBS and lysed using 50 mM TrisHCl pH 7.4, 500 mM NaCl, 1% Triton X-100, 0.5% sodium deoxycholate, 10 mM MgCl 2 , 1X protease and phosphatase inhibitors. Cleared lysates were incubated with recombinant GST or GST-CRIB-PBD obtained from DH5alpha cells as described above. Around 1-1.5 mg of lysate was incubated for 2 h at 4 °C with a similar amount of GST construct immobilized on glutathion sepharose beads. Beads were washed three times with 50 mM TrisHCl pH 7.4, 500 mM NaCl and 10 mM MgCl 2 , and prepared for SDS-PAGE analysis as described below.
SDS-PAGE and western blotting of mammalian cells.
Lysates were collected on ice by scraping cells in radioimmunoprecipitation assay buffer (150 mM NaCl, 10 mM Tris-HCl pH 7.5, 1 mM ethylenediaminetetraacetic acid (EDTA), 1% Triton X-100, 0.1% SDS, 1X protease and phosphatase inhibitors) and centrifuged for 10 min at 15,000 r.p.m. and 4 °C. The protein concentration was measured using Precision Red. Some 20-40 μ g of protein were resolved on NuPAGE Novex 4-12% Bis-Tris gels and transferred onto a nitrocellulose membrane using the Bio-Rad system. Membranes were blocked in 5% non-fat milk in TBS-T (10 mM Tris pH 8.0, 150 mM NaCl, 0.5% Tween 20) for 30 min before overnight incubation with primary antibodies at 4 °C. Membranes were washed three times for 5 min in TBS-T and incubated for 1 h with Alexa-Fluor conjugated secondary antibodies. Blots were then washed three times for 5 min and imaged using the LI-COR Odyssey CLx.
All images were then analysed using Image Studio Lite version 5.2.5.
Immunofluorescence of mammalian cells. Cells were collected and plated onto sterile 13 mm glass coverslips that were coated overnight at 4 °C with 10 μ g ml
of rat tail collagen I, 10 μ g ml −1 fibronectin or 10 μ g ml −1 laminin diluted in PBS. Coverslips were washed three times in PBS before seeding cells. Cells were fixed with 4% paraformaldehyde for 10 min, permeabilized (20 mM glycine, 0.05% Triton X-100) for 10 min and blocked with 5% BSA-PBS for 30 min. Primary and secondary antibodies were diluted in blocking buffer and incubated for 1 h in a dark and humidified chamber. Coverslips were washed twice in PBS and once in water before being mounted on glass slides using ProLong Gold antifade reagent. Images were taken using an inverted Olympus FV1000 confocal microscope using a Plan Apochromat N 63× /1.40 oil or an UPlanFL N 40× /1.30 oil objective.
Images were processed and analysed using Fiji software (ImageJ version 1.48t) 16 .
Membrane dynamics analysis. CHL-1 cells were transfected with GFP-LifeAct (5 μ g Amaxsa Kit T; programme T-020) and incubated overnight in complete DMEM. Cells were then plated onto a glass-bottom dish coated with laminin for 3 h before imaging within a contained unit at 37 °C and under 5% CO 2 . Time-lapse images were taken using a Nikon microscope with a CoolLED GFP filter set (470 nm LED) and a Nikon Plan APO VC 100× /1.4 NA oil immersion objective and captured using a Photometrics Prime camera. GFP images were taken at 1 frame per second for a total of 3 min. For each frame, a binary mask was made of the cell based on the intensity of its LifeAct signal, and the intensity of an associated edge image made by Canny edge detection. Differences between binary images from one frame to the next were used to find areas of extension or retraction, with extended areas positively valued and retracted areas negatively valued. Coordinates for an outline of the binary image of each frame were extracted from the ROI class in ImageJ and used to measure the mean intensity of the corresponding difference image in a 5 px × 5 px area. These values were then written for each cell to a new two-dimensional image that we refer to as an 'unwrapped kymograph' , with each two rows representing one frame and each column representing one outline coordinate point for that frame. After smoothing this unwrapped kymograph, areas of protrusion were identified by thresholding, with their extension in the y direction (time) measured. This gave us an estimate of the active lifetime of each protrusion, and a mean protrusion lifetime for each cell. Images were processed using MetaMorph and Fiji software.
The plugin used for creating the kymographs will be provided on reasonable request.
Rac1 photoactivation. Transfection protocol. Mouse embryo fibroblasts (MEFs)
were transiently transfected by electroporation (Amaxa Kit T) with 5 μ g of photoactivatable Rac1 plasmid 31 (pTriEx-LOV2-Ja-Rac1-mCherry). The transfected cells were suspended in complete DMEM medium and plated onto laminin-coated glass-bottom 35 mm dishes. After several hours, the medium was replaced with serum-free DMEM and incubated overnight in darkness.
Imaging. Imaging was performed on a Zeiss 880 confocal microscope with a stage incubator perfused with CO 2 . Time-lapse imaging of moderate mCherryexpressing cells was done for 150 frames at 2 s intervals between frames. Two images (1,024 × 1,024) were collected for each frame at 568 nm with bidirectional scanning averaged over two frames to image the mCherry tag, and a transmitted light detector to show a bright field image of the cell morphology, both at 1,024 × 1,024 resolution. An initial 29 frames (1 min) were collected with 568 nm excitation to document the baseline protrusive activity. Photoactivation of Rac1 was started at frame 30, and continued for each frame to 150, with a pulse of 458 nm excitation in a 100-pixel-diameter region of interest. The 568 nm excitation was at 7.5% laser power, with a gain of 600-800 depending on the brightness of the cell, and the pinhole was set at 300 to maximize the collection of light levels and depth of field to capture ruffles. The 458 nm excitation used a laser power of 10% and the scan speed was set for a pixel dwell time of 8 μ s.
Movies were processed using the plugin found in Supplementary Note 1.
Chemotaxis assay. Chemotaxis assays with WM852 human melanoma cells were performed as described previously 35 . Briefly, 8 × 10 4 cells were seeded onto fibronectin-coated coverslips and left overnight in serum-free RPMI. Coverslips were mounted onto Insall chambers with RPMI containing 10% FBS as the chemoattractant, and images were taken every 15 min for 48 h with a Nikon TE2000-E time-lapse microscope using MetaMorph software. Cells were manually tracked using the MTrackJ plugin in Fiji. All cells that moved independently of other cells were chosen for tracking. Approximately 120 cells were tracked for each condition from 3 independent repeats per condition (see also the Fig. 6 caption) .
Random migration assay for mammalian cells. Six-well glass-bottom plates were coated overnight as described above. Some 1 × 10 5 cells were plated and imaged every 10 min for 17 h using a Nikon TE2000 microscope with a Plan Fluor 10× /0.30 objective and equipped with a heated CO 2 chamber. Images were analysed using Fiji software 63 (ImageJ version 1.48t). Individual cells were tracked using the mTrackJ plugin, and spider plots were generated using the chemotaxis and migration tool plugin (version 1.01).
Dictyostelium discoideum cells. The axenic D. discoideum strain Ax3 was used as the WT. cyri knockout cells were generated in Ax3 genetic backgrounds. Ax3-derived napA KO cells have been described previously 64 . Cells were grown in HL5 Medium (Formedium) with 100 U ml −1 penicillin and 100 μ g ml −1 streptomycin in 10 cm plastic Petri dishes and incubated at 21 °C.
D. discoideum GFP-trap with formaldehyde cross-linking. Cells were collected in PBS and lysed by adding ice-cold 3× lysis/cross-linking buffer (1× buffer: 20 mM HEPES pH 7.4, 2 mM MgCl 2 , 3% formaldehyde, 0.2% Triton X-100). After 5 min with gentle agitation at 4 °C, formaldehyde was quenched for 10 min on ice using 1.75 M Tris pH 8.0. Samples were centrifuged at 22,000 g for 4 min at 4 °C. The pellet was successively washed and resuspended with 1 ml of ice-cold quenching buffer (0.4 M Tris pH 8.0, 0.2% Triton X-100), wash buffer A (100 mM HEPES pH 7.4, 2 mM MgCl 2 , 0.2% Triton X-100) and wash buffer B (100 mM HEPES pH 7.4, 2 mM MgCl 2 ), with a 3 min centrifugation step between washes. Final resuspension was performed using 1 ml of ice-cold radioimmunoprecipitation assay buffer (50 mM Tris-HCl pH 8.0, 150 mM NaCl, 0.5% Triton X-100, 0.5% sodium deoxycholate, 0.15% SDS, 5 mM EDTA, 2 mM DTT) and incubated for 1 h at 4 °C with gentle agitation. Supernatants were mixed with pre-equilibrated GFP-Trap beads (ChromoTek) following manufacturer's protocol. Beads were washed three times with 50 mM Tris-HCl pH 8.0, 150 mM NaCl and 5 mM EDTA, followed by one wash with 10 mM Tris-HCl pH 8.0. Samples were eluted after incubation with 2× SDS loading buffer and heated for 10 min at 70 °C before loading for SDS-PAGE.
D. discoideum GFP-NAP1 'in-gel' proteolytic digestion: mass spectrometry analysis. Eluates from GFP-NAP1 immunoprecipitation were separated by SDS-PAGE and stained with Coomassie blue. Each gel lane was divided into six slices and digested 65 . Tryptic peptides from in-gel digestions were separated by nanoscale C 18 reverse-phase liquid chromatography using an EASY-nLC II (Thermo Fisher Scientific) coupled online to a Linear Trap Quadrupole Orbitrap Velos mass spectrometer (Thermo Scientific) and desalted using a pre-column C18 NS-MP-10 100 μ m i.d. × 0.2 cm of length (NanoSeparations). Elution was at a flow of 300 nl min −1 over a 90 min gradient, into an analytical column C18 NS-AC-11 75 μ m i.d. × 15 cm of length (NanoSeparations). For the full scan, a resolution of 30,000 at 400 Th was used. The top ten most intense ions were selected for fragmentation in the linear ion trap using collision-induced dissociation with a maximum injection time of 25 ms or a target value of 5,000 ions. Mass spectrometry data were acquired using the Xcalibur software (Thermo Fisher Scientific).
The raw data obtained were processed with MaxQuant version 1.5.5.1 (ref. 66 ), and the Andromeda peak list files (.apl) generated were converted to Mascot generic files (.mgf) using APL to MGF Converter (http://www.wehi.edu.au/people/ andrew-webb/1298/apl-mgf-converter). Generated MGF files were searched using Mascot (Matrix Science, version 2.4.1), querying dictyBase 67 (12, 764 entries) plus an in-house database containing common proteomic contaminants and the sequence of GFP-NAP1. The common contaminant and reverse hits (as defined in the MaxQuant output) were removed.
Mascot was searched assuming trypsin digestion allowing for two miscleavages with a fragment ion mass tolerance of 0.6 Da and a parent ion tolerance of 15 ppm. The iodoacetamide derivative of cysteine was specified in Mascot as a fixed modification, and oxidation of methionine and phosphorylation of serine, threonine and tyrosine were specified in Mascot as variable modifications. Scaffold (version 4.3.2; Proteome Software) was used to validate tandem mass spectrometry-based peptide and protein identifications. Peptide identifications were accepted if they could be established at greater than 95.0% probability, as specified by the PeptideProphet algorithm, resulting in a peptide false discovery rate (FDR) of 0.63% 20 . For label-free quantification, proteins were quantified according to the label-free quantification algorithm available in MaxQuant 68 . Significantly enriched proteins were selected using a Welch's test analysis with a 5% FDR.
The mass spectrometry proteomics data have been deposited to the ProteomeXchange Consortium via the PRIDE partner repository with the dataset identifier PXD010460.
Generation and validation of the cyri knockout and rescued D. discoideum. The primers used are detailed in Supplementary Table 5 .
Standard methods were used for the construction of all Dictyostelium knockout and re-expression vectors 69 . A linear CYRI knockout construct (2,758 base pairs (bp) in length), which consisted of a blasticidin resistance (Bsr) cassette flanked by sequences matching 5′ and 3′ regions in the CYRI (DDB_G0272190 identifier at dictybase.org) gene locus (18 pb cross-over), was made by PCR amplification using primers set 1 (5′ arm) and set 2 (3′ arm). PCR-amplified arms were combined with the Bsr cassette using primers set 3.
Knockout clones were screened/validated by PCR, using primers set 4. The cyri knockout yielded a 2,450-bp PCR product and random integrants (clones with a knockout construct integration elsewhere in the genome), and the WT yielded a 1,983-bp PCR product.
The vector for expression of untagged CYRI was obtained by subcloning CYRI's genomic coding region into pDM358 (ref. 69 ). A REMI 37 (non extrachromosomal) vector was derived from this by removal of the Dictyostelium plasmid propagation genes and re-ligation of the vector backbone. This construct, while still having a strong promoter, is expected to be present in just one copy per cell.
Transformation of D. discoideum. Some 3.0 × 10 7 cells per transformation were first centrifuged (3 min, 330g, 4 °C), washed with 10 ml ice-cold electroporation buffer (E-buffer; 10 mM sodium phosphate buffer pH 6.1 and 50 mM sucrose) and resuspended in 400 μ l ice-cold E-buffer. Cells were transferred into an ice-cold 0.2 cm electroporation cuvette and incubated for 5 min with 0.5-1.0 μ g of DNA on ice. Cells were electroporated (BTX ECM 399; Harvard Apparatus) at 500 V, giving a time constant of 3-4 ms. Cells were immediately transferred to HL5 Medium in Petri dishes. Appropriate selection (50 μ g ml −1 hygromycin or 10 μ g ml −1 G418) was added the next day. For REMI transfections, 10 μ g of linearized DNA and 50 U of restriction enzyme were used in 0.4 cm cuvettes with a Bio-Rad Gene Pulser II set at 1.2 kV and 3 μ F.
D. discoideum CYRI inclusion body purification. BL21(DE3)pLysS cells were grown to absorbance at 600 nm of 0.2 and induced with 0.2 mM IPTG for 4 h. Cells were pelleted, frozen and resuspended with 80 ml of lysis buffer (50 mM Tris-HCl pH 8.0, 25% sucrose (w/v), 1 mM EDTA) per 100 g of cells. Cells were lysed by adding 1% lysozyme (w/v) and kept on ice for 30 min. Lysate was resuspended with 10 mM MgCl 2 , 1 mM MnCl 2 and 10 μ g ml −1 DNase I, and kept for another 30 min on ice. Finally, 200 ml of detergent buffer (0.2 M NaCl, 1% deoxycholic acid (w/v), 1% NP-40, 20 mM Tris-HCl pH 7.5, 2 mM EDTA) was added to the lysate, which was then centrifuged at 5,000g for 10 min. The pellet was then washed in 0.5% NP-40 and 1 mM EDTA, and this step was repeated until a tight white pellet was obtained.
D. discoideum CYRI antibody production. Inclusion bodies were dissolved in sample buffer with DTT and loaded onto a 10% Bis-Tris acrylamide gel at 70 V at 4 °C. The gel was Coomassie stained and fragments of the band corresponding to CYRI were sent to Biogenes for injection into two rabbits. Bleeds were collected every second week after initial immunization/boost and tested by western blot.
The terminal bleed from rabbit 27724 after the fifth boost was used at 1:100.
D. discoideum under-agarose chemotaxis assay. This assay was based on a previous study 70 . The surface of the 30 mm glass-bottom dish (MatTek) was coated with 10 mg ml −1 BSA for 10 min, washed with distilled water and dried for 5 min inside a laminar-flow cabinet. Then, 0.4% w/v SeaKem GTG Agarose in SIH Medium (Formedium) containing 10 μ M folate was poured and set for 1 h. A well was cut in the agarose and 2 × 10 6 cells ml −1 placed inside. After 3-4 h, cells were imaged by phase contrast and differential interference contrast (DIC) microscopy with a Nikon Eclipse TE2000-E microscope system equipped with a QImaging RETIGA EXi FAST 1394 CCD camera and a pE-100 LED illumination system (CoolLED) at 525 nm. A 10× /0.45 NA Ph1 objective and a 60× /1.40 NA apochromatic DIC objective were used for phase contrast and DIC, respectively. Imaging was controlled using Micro-Manager 1.4.9 software. All microscopy was carried out at room temperature and images were analysed with ImageJ/Fiji 1.49i.
The pseudopod rate and split frequency were analysed from the DIC movies and manually quantified frame by frame. For analysis of cell circularity, speed and migration parameters, automated tracking plugins were developed for ImageJ (see Plugin2 in Supplementary Note 2). More information will be supplied on reasonable request. D. discoideum development assay. Cells were harvested from axenic growth plates, washed twice in phosphate buffer (10 mM Na/K phosphate pH 6.5) containing 2 mM MgCl 2 and 1 mM CaCl 2 , and plated on 1% w/v agar prepared in the same buffer. For time-lapse imaging, we used a Nikon Eclipse TE2000-E microscope fitted with a Prior ProScan II moving stage, and equipped with a QImaging RETIGA EXi FAST 1394 CCD camera and a pE-100 LED illumination system (CoolLED) at 525 nm. cAMP needle assay. Cells were developed as described above until territories began to form, indicating production and responsiveness to cAMP waves. Cells were harvested and placed into phosphate buffer, and their response to 10 μ M cAMP (Eppendorf Injectman NI2 microinjector with Femtotips II) was monitored by time-lapse microscopy (1 frame every 5 s) using a Zeiss Axio Vert A1 body with a plan/neofluar 20× 0.5 NA objective combined with a QImaging RETIGA camera.
HSPC300-GFP analysis. WT or cyri knockout Ax3 cells were transfected with HSPC300-GFP as described above, and time-lapse movies were obtained using a Zeiss 880 confocal microscope. Processed images were used to obtain the unwrapped kymographs. The plugin used for this analysis will be provided on reasonable request.
Three-dimensional MDCK cysts: culture. shRNA-expressing MDCK cells were split 1:10 the day before plating in three dimensions, in puromycin-free medium. Chilled 8-well chamber slides were coated by spreading 5 μ l of undiluted Matrigel over the well surface and transferred to a 37 °C incubator for 10 min. MDCK cells were diluted to 4 × 10 4 cells ml −1 in puromycin-free medium and thoroughly disaggregated by pipetting. Matrigel was then diluted to 4% in Minimum Essential Medium and mixed with a similar volume of cells diluted at 1.5 × 10 4 cells ml
, bringing the final Matrigel concentration to 2%. Wells were filled with 300 μ l of the cell and Matrigel mix, and cysts were grown for 5 d at 37 °C.
Three-dimensional MDCK cysts: immunofluorescence and imaging. Medium was aspirated and wells were quickly washed twice with PBS. Cysts were fixed using 4% formaldehyde for 10 min, washed, and permeabilized for 10 min at room temperature using 0.5% Triton X-100 diluted in PBS. Cells were blocked for 30 min using PBS fish skin saponin (PFS) (0.7% (w/v) fish skin gelatin in 0.025% Saponin-PBS). Primary antibodies were diluted in PFS and incubated overnight at 4 °C with gentle shaking. Cysts were washed three times in PFS at room temperature. Secondary antibodies, nuclear dye and phalloidin were diluted at 1:200 in PFS and incubated for 1 h at room temperature before further washes. Chambers were then kept sealed in 0.02% NaN 3 -PBS at 4 °C until analysis. Cysts were imaged using the Nikon A1R Z6005 confocal microscope using either a Plan Apochromat 20× /0.75 DIC N2 or a Plan Fluor 10× /0.30 DIC L/N1 objective. To sharpen the images, factor line averaging was performed over 4 consecutive images. Z-stack images were acquired with a 4 μ m increment step from the bottom to the top of the cyst.
Statistics and reproducibility. Datasets were analysed using Prism5 version 5.0c and Prism7. Differences between groups were tested for normality and then analysed using the appropriate statistical test, as mentioned in each figure legend. Error bars represent s.e.m. unless otherwise stated. Significance levels are given as follows: NS (not significant): P > 0.05; *P ≤ 0.05; **P ≤ 0.01; ***P ≤ 0.001. A Cochran-Mantel-Haenszel test was generated using R software and P values are mentioned when appropriate.
All experiments were repeated at least three times independently as biological repeats unless otherwise stated, and they always gave similar results. Individual values are available in Supplementary Table 6 .
Code availability. The code used for analysis of cell protrusions in Fig. 5 is available in Supplementary Note 1. The code used for tracking Dictyostelium migration under agarose is available in Supplementary Note 2. Home-made plugins from this study will be made available from the corresponding authors upon reasonable request. 
Statistical parameters
When statistical analyses are reported, confirm that the following items are present in the relevant location (e.g. figure legend, table legend, main text, or Methods section).
n/a Confirmed
The exact sample size (n) for each experimental group/condition, given as a discrete number and unit of measurement An indication of whether measurements were taken from distinct samples or whether the same sample was measured repeatedly
The statistical test(s) used AND whether they are one-or two-sided
Only common tests should be described solely by name; describe more complex techniques in the Methods section.
A description of all covariates tested A description of any assumptions or corrections, such as tests of normality and adjustment for multiple comparisons A full description of the statistics including central tendency (e.g. means) or other basic estimates (e.g. regression coefficient) AND variation (e.g. standard deviation) or associated estimates of uncertainty (e.g. confidence intervals)
For null hypothesis testing, the test statistic (e.g. F, t, r) with confidence intervals, effect sizes, degrees of freedom and P value noted For manuscripts utilizing custom algorithms or software that are central to the research but not yet described in published literature, software must be made available to editors/reviewers upon request. We strongly encourage code deposition in a community repository (e.g. GitHub). See the Nature Research guidelines for submitting code & software for further information.
nature research | reporting summary All studies must disclose on these points even when the disclosure is negative.
Sample size
For cell migration studies or chemotaxis assays, sample sizes were chosen according to how many cells could reliably be tracked in the assay. For manual tracking, we tracked at least 30 cells per experiment with 3 independent repeats. In some cases, where automated tracking was used, sample sizes were larger e.g. in Figure 6j -n and Supplementary Figure 5g -h, more than 500 cells were tracked. The sample size was not pre-chosen, but was kept constant within an experiment and was based on the maximum number of cells that could be reliably analysed within a reasonable time frame.
Data exclusions We did not exclude any data points.
Replication
All experiments were reproduced at least 3 times independently, except for 1) the SPR, which has been done once, in a forward and reverse way. 2) PLA experiment from Supplementary Figure 2k , only done twice, and WB for parental WM852 cell line only done twice. All attempts at replication were successful and all experiments can be reproduced.
Randomization We did not randomise our experiments, but independent cultures or passages were used for each independent repeat and done on different days.
Blinding
Our studies were not done blind, but we used computer-based tracking and analysis with as many cells as was practical to track/analyse to minimise bias.
Reporting for specific materials, systems and methods Obtaining unique materials All unique materials generated and described in this study will be provided upon reasonable request to the corresponding authors. Please request Dictyostelium reagents from Robert Insall and mammalian reagents from Laura Machesky.
